Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction

DOI PDF 1 Citations
  • Jawad H. Butt
    Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
  • Kieran F. Docherty
    BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland
  • Mark C. Petrie
    BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland
  • Morten Schou
    Department of Cardiology, Herlev-Gentofte University Hospital, Herlev, Denmark
  • Mikhail N. Kosiborod
    St Luke’s Mid America Heart Institute, University of Missouri–Kansas City
  • Eileen O’Meara
    Department of Cardiology, Montreal Heart Institute, Montreal, Ontario, Canada
  • Tzvetana Katova
    Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria
  • Charlotta E. A. Ljungman
    Department of Molecular and Clinical Medicine and Cardiology, Sahlgrenska Academy, Gothenburg, Sweden
  • Mirta Diez
    Division of Cardiology, Institute Cardiovascular de Buenos Aires, Buenos Aires, Argentina
  • Modele O. Ogunniyi
    Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia
  • Anna Maria Langkilde
    Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
  • Mikaela Sjöstrand
    Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
  • Daniel Lindholm
    Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
  • Olof Bengtsson
    Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
  • Felipe A. Martinez
    Universidad Nacional de Córdoba, Córdoba, Argentina
  • Piotr Ponikowski
    Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wrocław, Poland
  • Marc S. Sabatine
    TIMI Study Group, Brigham and Women’s Hospital, Boston, Massachusetts
  • Scott D. Solomon
    Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
  • Pardeep S. Jhund
    BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland
  • John J. V. McMurray
    BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland
  • Lars Køber
    Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Bibliographic Information

Other Title
  • A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial

Journal

  • JAMA Cardiology

    JAMA Cardiology 6 (6), 678-, 2021-06-01

    American Medical Association (AMA)

Citations (1)*help

See more

Report a problem

Back to top